Clinical trial Recruiting at 1 site Observational Ages 18 to 75 Women only

Bioelectrical impedance comparison of body composition in women with functional dyspepsia and healthy women

Official title: Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia

Run by Universitair Ziekenhuis Brussel · NCT07196735 · Data updated 2026-11-12

This project will use a quick, noninvasive bioelectrical impedance scan to see if women with functional dyspepsia have different fat mass, fat‑free mass, or phase angle compared with healthy women.

More Functional Dyspepsia trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexWomen only
Enrollment40 (estimated)
SponsorUniversitair Ziekenhuis Brussel
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Brussels)
StatusRecruiting
StartedSeptember 18, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 3, 2025
Trial IDNCT07196735 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 to 75 who meet Rome IV criteria for functional dyspepsia with an upper GI endoscopy in the past 12 months that excludes organic disease (mild gastritis allowed) are the intended participants, along with age-matched healthy women as controls.

Probably not a fit

Men and patients with known organic GI disease, untreated H. pylori infection, major systemic or autoimmune disorders affecting the GI tract, significant psychiatric illness, substance abuse, or recent major abdominal surgery are unlikely to be eligible or to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will compare bioelectrical impedance analysis (BIA) measurements—including phase angle, fat-free mass, and fat mass—between women who meet Rome IV criteria for functional dyspepsia and age-matched healthy women. All participants will undergo a noninvasive BIA measurement at UZ Brussel and clinical records including recent upper GI endoscopy will be reviewed to confirm eligibility. The protocol excludes participants with identified organic GI disease, untreated H. pylori, major systemic or psychiatric disorders, or certain prior abdominal surgeries to reduce confounding. Results will report group differences and may identify body composition features associated with functional dyspepsia symptoms.

Why it matters

Potential benefit: If differences are found, the results could help identify body composition markers that inform nutritional counseling or targeted management for women with functional dyspepsia.

How similar studies have gone: BIA and phase angle have been used in other gastrointestinal and nutritional research with some reported associations to symptoms or outcomes, but application specifically to functional dyspepsia is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18 - 75 years
* Fulfilling the ROME IV criteria for functional dyspepsia (for FD patients)
* FD unexplained by upper GI endoscopy during the past 12 months (mild gastritis allowed) (for FD patients).

Exclusion Criteria:

* Clinical suspicion of an organic disorder different from FD (patients can be included when this disorder had been excluded);
* Abnormality on upper GI endoscopy other than mild gastritis (for FD patients).
* Known reflux oesophagitis Los Angeles grade C or D, known Barrett oesophagus, peptic stricture.
* H pylori infection, unless treated at least 6 months before;
* Known inflammatory bowel disorder;
* Known major intestinal motility disorder;
* Alcohol (defined as more than 14 U per week) or other substance abuse;
* Active psychiatric disorder;
* Known systemic or auto-immune disorder with implication for the GI system;
* Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy);
* Any prior diagnosis of cancer other than basocellular carcinoma;
* Current chemotherapy;
* History of gastro-enteritis in the past 12 weeks;
* Dietary supplements unless taken at a stable dose for more than 12 weeks;
* Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed);
* Treatment with PPI's during the past 8 weeks
* Pregnancy.

Where it's running

  • UZ Brussel
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.